Close Phone: (858) 882-2800
Close Phone: (858) 882-2800
Agena Bioscience Announces Collaboration with PerkinElmer More
Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy WorkflowSan...
Agena Announces MassARRAY® Technology Selected for Participation in CANCER-ID Consortium More
San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that...
Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More
San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement...
GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More
New York, NY (360DX), June 6, 2018 – For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going...
Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More
San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the...
Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union More
San Diego, CA, November 30, 2017 – Agena Bioscience, a global provider of molecular genetic solutions, today announced...
Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More
The collaboration will focus on results interpretation for cancer genomics.San Diego, CA, October 5, 2017– Agena Bioscience,...
Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY® System More
San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting...
Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights™ More
MassARRAY Insights providers will aid in results interpretationSan Diego, CA, September 19, 2017– Agena Bioscience, a...
Intermountain Precision Genomics Launches Antidepressant PGx Panels Developed on Agena MassARRAY® More
NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the...
MassARRAY® System Selected for Illinois State Cystic Fibrosis Screening of Newborns More
San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public...
Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance More
HEARTDECODE® Software and Assays Designed for Use with the MassARRAY® DX SystemSan Diego, CA,...